Showing 4141-4150 of 4164 results for "".
- Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Studyhttps://modernod.com/news/wearing-glasses-boosts-income-by-a-third-in-low-income-communities-finds-landmark-new-study/2482212/A pair of reading glasses increases the earnings of people in low-income communities by 33%, according to new research. A new randomized controlled trial finds that the provision of reading glasses improves livelihoods and quality of life and reduces poverty. VisionSpring, BRAC, an
- Inflammasome Therapeutics Announces First Patient Dosed in Phase 1 DME Study of the Dual Inflammasome Inhibitor K8https://modernod.com/news/inflammasome-therapeutics-announces-first-patient-dosed-in-phase-1-dme-study-of-the-dual-inflammasome-inhibitor-k8/2482069/Inflammasome Therapeutics announced the first patient has been dosed in a phase 1 study of a novel compound in the treatment of diabetic macular edema (DME). The 24-week study (ClinicalTrials.gov ID NCT05699759) is designed to assess safety and initial evidence of efficacy. Th
- Sandoz Announces Results from Mylight Phase 3 Study for Biosimilar Aflibercepthttps://modernod.com/news/sandoz-announces-results-from-mylight-phase-3-study-for-biosimilar-aflibercept/2481777/Sandoz released positive results from the MYLIGHT phase 3 confirmatory efficacy and safety study for its biosimilar aflibercept for wet macular degeneration (AMD). The Mylight phase 3 confirmatory efficacy and safety study (ClinicalTrials.gov NCT04864834) met its pri
- Sydnexis Secures $45 Million Series B Financing to Advance Myopia Drug Candidatehttps://modernod.com/news/sydnexis-secures-45-million-series-b-financing/2479442/Sydnexis announced the completion of a $45 million Series B financing to fund Sydnexis’ lead candidate, SYD-101, through completion of the fully enrolled pivotal Phase 3 STAAR study for the treatment of progressive myopia in children. The financing was led by Visionary Ventures, Blue Stem
- Heine Announces Launch of Omega 600 Lightweight Indirect Ophthalmoscopehttps://modernod.com/news/heine-announces-launch-of-new-omega-600-lightweight-indirect-ophthalmoscope/2478842/Heine has launched its newest indirect ophthalmoscope, the Omega 600. The Omega 600 includes a new design that makes it the lightest high-end indirect on the market courtesy of a new ultralight battery, according to Heine. Other new features are Heine’s visionBOOST technology, which is des
- J&J Looking to Enroll 60,000 Participants in Coronavirus Vaccine Trialhttps://modernod.com/news/jj-looking-to-enroll-60000-participants-in-coronavirus-vaccine-trial/2478185/A phase 3 trial Johnson & Johnson is planning to get under way in September to test its coronavirus vaccine candidate Ad26.COV2.S is looking to recruit up to 60,000 participants globally, the company confirmed Thursday. The targeted enrollment, first reported on the ClinicalTrials.gov databas
- Prevent Blindness Unveils New Brand Identity, Logo and Websitehttps://modernod.com/news/prevent-blindness-unveils-new-brand-identity-logo-and-website/2477772/Prevent Blindness announced the launch of its new brand identity, logo, and website. The launch coincides with the organization’s new “Be a Visionary” campaign: a call to action to join in the sight-saving efforts of Prevent Blindness. The new identity is designed to refl
- Luxottica to Donate Hundreds of Thousands of Medical Masks, Outlines COVID-19 Safety and Relief Effortshttps://modernod.com/news/luxottica-to-donate-hundreds-of-thousands-of-medical-masks-outlines-covid-19-safety-and-relief-efforts/2477526/Responding to the COVID-19 pandemic, Luxottica Group has taken a number of steps, both in North America and Italy, to protect customers, employees, partners and medical workers, according to a VisionMonday
- US ECPs’ Business Concerns and Stress Levels Grow, as Coronavirus Pandemic Impact Widenshttps://modernod.com/news/us-ecps-business-concerns-and-stress-levels-grow-as-coronavirus-pandemic-impact-widens/2477464/As the number of COVID-19 cases grow and more parts of the U.S. put “shelter-in-place” requests and mandates into place due to the coronavirus pandemic, the impact is growing more pronounced in the provider sector of business, according to a VisionMonday
- The American Optometric Association Urges Employers to Pledge to Make 2020 the Year of the Eye Examhttps://modernod.com/news/the-american-optometric-association-urges-employers-to-pledge-to-make-2020-the-year-of-the-eye-exam/2477180/As part of the American Optometric Association’s (AOA) #2020EyeExam initiative, the organization and doctors of optometry nationwide are calling upon visionary companies across the country to join the 2020 Employer Pledge program–affirming the importance of caring for the overall health and